Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment

Psychiatry Research

Volumn 113, Issue 1-2, 2002, Pages 139-149

  Agelink, Marcus W ^a   Boz, Cavit ^b   Ullrich, Heiko ^a   Andrich, Jürgen ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b University of Trabzon   (Turkey)

Author keywords

Antidepressive treatment; Autonomic nervous system; Heart rate variability; Major depression; Mortality, cardiovascular

Indexed keywords

AMITRIPTYLINE; DOXEPIN; IMIPRAMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BREATHING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEUROMODULATION; PRIORITY JOURNAL; RATING SCALE; SEX DIFFERENCE; SMOKING; VAGUS NERVE STIMULATION;

EID: 0037114836     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(02)00225-1     Document Type: Article

References (47)

1. Agelink M.W., Lemmer W., Malessa R., Zeit T., Klieser E. Improvement of neurocardial vagal dysfunction after successful antidepressive treatment with electro-convulsive therapy. European Psychiatry. 13:(Suppl. 4):1998;259S.
2. Agelink M.W., Majewski T., Wurthmann C., Postert T., Linka T., Rotterdam S., Klieser E. Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone. Journal of Affective Disorders. 62:2001;187-198.
3. Agelink M.W., Malessa R., Baumann B., Majewski T., Akila F., Zeit T., Ziegler D. Standardised tests of heart rate variability (HRV): normal ranges obtained from 309 healthy humans and effects of age, gender and heart rate. Clinical Autonomic Research. 11:2001;99-108.
4. Akselrod S., Gordon D., Ubel F.A., Shannon D.C., Barger A.C., Cohen R.J. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat to beat cardiovascular control. Science. 213:1981;220-222.
5. Balogh S., Fitzpatrick D.F., Shelton D.G.S., Hendricks E., Paige S.R. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacology Bulletin. 29:1993;201-206.
6. Barefoot J.C., Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 93:1996;1976-1980.
7. Ben-David J., Zipes D.P. Autonomic neural modulation of cardiac rhythm: Part I. Basic concepts. Modern Concepts of Cardiovascular Disease. 57:1988;41-46.
8. Carney R.M., Freedland K.E., Stein P.K., Skala J.A., Hoffmann P., Jaffe A.S. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosomatic Medicine. 62:2000;639-647.
9. Dalack G.W., Roose S.P. Perspectives on the relationship between cardiovascular disease and affective disorder. Journal of Clinical Psychiatry. 51:(Suppl.):1990;4-9.
10. Eckberg D.L. Parasympathetic cardiovascular control in human disease: a critical review of methods and results. American Journal of Physiology. 239:1980;H581-H593.
11. Eckberg D.L. Sympathovagal balance: a critical appraisal. Circulation. 96:1997;3224-3232.
12. Elger G., Hoppe C., Falkai P., Rush A.J., Elger C.E. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Research. 42:2000;203-210.
13. Ewing D.J., Clarke B.F. Autonomic neuropathy: its diagnosis and prognosis. Journal of Clinical Endocrinology and Metabolism. 15:1986;855-889.
14. George M.S., Sackeim H.A., Rush A.J., Marangell L.B., Nahas Z., Husain M.M., Lisanby S., Burt T., Goldman J., Ballenger J.C. Vagus nerve stimulation: a new tool for brain research and therapy. Biological Psychiatry. 47:2000;287-295.
15. Guinjoan S.M., Bernabo J.L., Cardinali D.P. Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. Journal of Neurology, Neurosurgery and Psychiatry. 58:1995;299-302.
16. Johnson R.H., Robinson B.J. Mortality in alcoholics with autonomic neuropathy. Journal of Neurology, Neurosurgery and Psychiatry. 51:1988;476-480.
17. Kingwell B.A., Thompson J.M., Kaye D.M., McPherson G.A., Jennings G.L., Esler M.D. Heart rate spectral analysis, cardiac norepinephrine spillover and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation. 90:1994;234-240.
18. Kittayaphong R., Cascio W.E., Light K.C., Sheffield D., Golden R.N., Finkel J.B., Glekas G., Koch G.G., Sheps D.S. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosomatic Medicine. 59:1997;231-235.
19. Kleiger R.E., Miller I.P., Bigger J.T., Moss A.J. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. American Journal of Cardiology. 59:1987;256-262.
20. La Rovere M.T., Bigger J.T., Marcus F.I., Mortara A., Schwartz P.J. Baro-reflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 351:1998;478-484.
21. Lanza G.A., Pedrotti P., Rebuzzi A.G., Pasceri V., Quaranta G., Maseri A. Usefulness of the addition of heart rate variability to Holter monitoring in predicting in-hospital cardiac events in patients with unstable angina pectoris. American Journal of Cardiology. 80:1997;263-267.
22. Lederbogen F., Gernoth C., Weber B., Colla M., Kniest A., Heuser I., Deuschle M. Antidepressive treatment with amitriptyline and paroxetine: comparable effects on heart rate variability. Journal of Clinical Psychopharmacology. 21:2001;238-239.
23. Lesperance F., Frasure-Smith N., Talajic M. Major depression before and after myocardial infarction: its nature and consequences. Psychosomatic Medicine. 58:1996;99-110.
24. Low P.A., Pfeifer M.A. Standardization of clinical tests for practice and clinical trials. Low P.A. Clinical Autonomic Disorders. 1993;Little Brown and Co, Boston.
25. Lown B., Verrier R.L. Neural activity and ventricular fibrillation. New England Journal of Medicine. 294:1976;1165-1170.
26. Molgaard H., Sorensen K.E., Bjerregaard P. Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clinical Autonomic Research. 1:1991;233-237.
27. Moser M., Lehofer M., Hoehn-Saric R., McLeod D.R., Hildebrandt G., Steinbrenner B., Voica M., Liebmann P., Zapotoczky G. Increased heart rate in depressed subjects in spite of unchanged autonomic balance. Journal of Affective Disorders. 48:1998;115-124.
28. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease. Epidemiology, biology and treatment. Archives of General Psychiatry. 55:1998;580-592.
29. Nahshoni E., Aizenberg D., Sigler M., Zalsman G., Strasberg B., Imbar S., Weizman A. Heart rate variability in elderly patients before and after electroconvulsive therapy. American Journal of Geriatric Psychiatry. 9:2001;255-260.
30. Pagani M., Lombardi F., Guzzetti S., Rimoldi O., Furlan R., Pizzinelli P., Sandrone G., Malfatto G., Dell'Orto S., Piccaluga E., Turiel M., Baselli G., Cerutti S., Malliani A. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circulation Research. 59:1986;178-193.
31. Pomeranz B., Macauley R.J.B., Caudill M.A., Kutz I., Adam D., Gordon D. Assessment of autonomic function in humans by heart rate spectral analysis. American Journal of Physiology. 248:1985;H151-H153.
32. Post R.M. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Psychiatry. 149:1992;999-1010.
33. Rechlin T. The effects of amitriptyline, doxepine, fluvoxamine and paroxetine treatment on heart rate variability. Journal of Clinical Psychopharmacology. 14:1994;392-395.
34. Rechlin T., Weis M., Spitzer A., Kaschka W.P. Are affective disorders associated with alterations of heart rate variability? Journal of Affective Disorders. 32:1994;271-275.
35. Roose S.P., Glassman A.H., Attia E., Woodring S., Giardian E.G., Bigger J.T. Cardiovascular effects of fluoxetine in depressed patients with heart disease. American Journal of Psychiatry. 155:1998;660-665.
36. Roose S.P., Laghrissi-Thode F., Kennedy J.S., Nelson J.C., Bigger J.T., Pollock B.G., Gaffney A., Narayan M., Finkel M.S., McCafferty J., Gergel I. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 279:1998;287-291.
37. Rush A.J., Linden M., Zobel A. Vagusstimulation. Eine neue Behandlungsoption für chronifiziert depressive Erkrankungen. Fortschritte für Neurologie und Psychiatrie. 70:2002;297-302.
38. Schultz S.K., Anderson E.A., van de Borne P. Heart rate variability before and after treatment with electroconvulsive therapy. Journal of Affective Disorders. 44:1997;13-20.
39. Schwartz P.J., La Rovere M.T., Vanoli E. Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post myocardial infarction risk stratification. Circulation. 85:(Suppl. 1):1992;177-191.
40. Sloan R.P., Shapiro P.A., Bagiella E., Bigger J.T., Lo E.S., Gorman J.M. Relationship between circulation catecholamines and low frequency heart period variability as indices of cardiac sympathetic activity during mental stress. Psychosomatic Medicine. 58:1996;25-31.
41. Stein P.K., Carney R.M., Freedland K.E., Skala J.A., Jaffe A.S., Kleiger R.E., Rottman J.N. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. Journal of Psychosomatic Research. 48:2000;493-500.
42. Szabo B.M., van Veldhuisen D.J., van der Veer N., Brouwer J., De Graeff P.A., Crijns H.J. Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. American Journal of Cardiology. 79:1987;978-980.
43. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Circulation. 93:1996;1043-1065.
44. Tucker P., Adamson P., Miranda R., Scarborough A., Williams D., Groff J., McLean H. Paroxetine increases heart rate variability in panic disorders. Journal of Clinical Psychopharmacology. 17:1997;370-376.
45. Tulen J.H.M., Bruijn J.A., de Man K.J., Pepplinkhuizen L., van den Meiracker A.H., Man in't Veld A.J. Cardiovascular variability in major depressive disorder and effects of imipramine and mirtazapine. Journal of Clinical Psychopharmacology. 16:1996;135-145.
46. Wittchen H.U., Zaudig M., Schramm E. Strukturiertes Klinisches Interview für DSM-III-R. Second Ed :1991;Beltz Test GmbH, Weinheim.
47. Yeragani K., Pohl R., Balon R., Ramesh C., Glitz D., Jung I., Sherwood P. Heart rate variability in patients with major depression. Psychiatry Research. 37:1991;35-46.